A detailed history of Laird Norton Trust Company, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 20,345 shares of ABBV stock, worth $3.69 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
20,345
Previous 27,441 25.86%
Holding current value
$3.69 Million
Previous $4.71 Million 14.64%
% of portfolio
0.53%
Previous 0.66%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $1.16 Million - $1.41 Million
-7,096 Reduced 25.86%
20,345 $4.02 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.5 Million - $1.71 Million
-9,384 Reduced 25.48%
27,441 $5 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $4.57 Million - $5.15 Million
33,215 Added 920.08%
36,825 $5.71 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $3,206 - $3,711
24 Added 0.67%
3,610 $538,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $495,979 - $594,809
3,586 New
3,586 $579,000
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $163,767 - $208,202
-1,190 Reduced 23.76%
3,819 $584,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $6,203 - $7,696
47 Added 0.95%
5,009 $812,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $38,889 - $49,206
362 Added 7.87%
4,962 $671,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $35,537 - $40,340
334 Added 7.83%
4,600 $496,000
Q2 2021

Aug 09, 2021

SELL
$105.21 - $117.21 $134,668 - $150,028
-1,280 Reduced 23.08%
4,266 $480,000
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $23,938 - $26,353
234 Added 4.41%
5,546 $594,000
Q4 2020

Feb 26, 2021

BUY
$80.49 - $108.67 $427,562 - $577,255
5,312 New
5,312 $569,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $321B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Laird Norton Trust Company, LLC Portfolio

Follow Laird Norton Trust Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laird Norton Trust Company, LLC with notifications on news.